Compare Alcon AG (ALC) vs Invesco Galaxy Bitcoin ETF (BTCO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Invesco Galaxy Bitcoin ETF — how do they compare? Alcon AG trades at $66.89 (market cap $32.69B), while Invesco Galaxy Bitcoin ETF trades at $61.5. The key difference: Alcon AG pays a 0.54% dividend while Invesco Galaxy Bitcoin ETF pays none, and Alcon AG is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| ALC | BTCO | |
|---|---|---|
Market Cap | $32.69B | — |
Sector | Health | Crypto-linked |
52-Week High | $92.22 | $125.14 |
52-Week Low | $62.02 | $58.40 |
Enterprise Value | $36.28B | — |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
BTCO is trading at $63.38, up 3.63% today, but technical indicators signal a bearish trend with moving averages showing significant selling pressure. The stock faces resistance at $64 and support at $58. Recent news highlights investor caution toward cryptocurrency-related assets, though BTCO's specific financial metrics remain undisclosed in available data.
The outlook for BTCO is cautious due to bearish technical signals and negative sentiment around crypto-exposed stocks. Key risks include market volatility and reliance on cryptocurrency trends. Investors should await clearer fundamental data to assess valuation and growth prospects amid current headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Invesco Galaxy Bitcoin ETF
BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.
Read more on BTCO →
